title: How Metabolic Diseases Impact the Use of Antimicrobials: A Formal Demonstration in the Field of Veterinary Medicine.
abstract: Decreasing the use of antimicrobials has become a primary objective for both human and veterinary medicine in many countries. Medical prevention and good nutrition are seen as key parameters for reducing antimicrobial use. However, little consideration has been given to how metabolic diseases may influence the use of antimicrobials in humans and animals through limiting the prevalence and severity of infectious diseases. To quantify this relationship using the example of a common metabolic disease in dairy cows (subclinical ketosis, SCK), we constructed a stochastic model reporting the total quantity of curative antimicrobials for a given population with the prevalence of cows at risk for SCK. We considered the prevalence of SCK, the relative risk of the disease in cases of SCK compared to no SCK and the use of antimicrobials to treat SCK-induced infectious diseases. Reducing the percentage of cows at risk for SCK from 80% to 10% was associated with an average decrease in the use of antimicrobials of 11% (prevalence of SCK from 34% to 17%, respectively) or 25% (prevalence of SCK from 68% to 22%, respectively), depending on the relative risk to contract SCK if risk was present. For a large percentage of the cows at risk for SCK, using a preventive bolus of monensin reduced the use of curative antimicrobials to the same level that was observed when the percentage of cows at risk for SCK was low. The present work suggests similar approaches for obesity and diabetes.
authors.affiliation: IHAP, Université de Toulouse, INRA, ENVT, Toulouse, France.
authors.forename: Didier
authors.initials: D
authors.lastname: Raboisson
authors.affiliation: IHAP, Université de Toulouse, INRA, ENVT, Toulouse, France.
authors.forename: Maxime
authors.initials: M
authors.lastname: Barbier
authors.affiliation: ODR, INRA, Toulouse, France.
authors.forename: Elise
authors.initials: E
authors.lastname: Maigné
mesh_terms: D000818:Animals; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000494:pharmacology*; D002417:Cattle; D002418:Cattle Diseases / Q000209:etiology*; D008659:Metabolic Diseases / Q000209:etiology* / Q000662:veterinary*; D008985:Monensin / Q000009:adverse effects / Q000494:pharmacology; D015995:Prevalence
chemical_list: D000890:Anti-Infective Agents; D008985:Monensin